Fund Holdings — VR Adviser, LLC

Total Portfolio Value:
$1.33B
Total Bought:
$154.18M
Total Sold:
$96.80M
Net Transaction:
+$57.38M
Notable People:
Evan Wolfe Neu, Jessica Tong Baron
Securities
▲▼
SharesValue
Q1 2025
▲▼
Q2 2025
▲▼
Change
▲▼
Q1 2025
▲▼
Q2 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Apogee Therapeutics Inc8,493,3218,493,3210$317.31M$368.86M27.64%+$51.55M
Ocular Therapeutix, Inc.(OCUL)12,762,46212,762,4620$93.55M$118.44M8.88%+$24.89M
Metsera Inc3,750,6623,750,6620$102.09M$106.71M8.00%+$4.61M
Enliven Therapeutics Inc4,026,3314,026,3310$79.24M$80.77M6.05%+$1.53M
Kalvista Pharmaceuticals Inc6,703,9856,728,985+25,000$77.36M$76.07M5.70%-$1.29M
ORIC Pharmaceuticals, Inc.(ORIC)3,182,5276,596,885+3,414,358$17.76M$66.96M5.02%+$49.20M
Viridian Therapeutics, Inc.(VRDN)3,882,7093,882,7090$52.34M$54.28M4.07%+$1.94M
Oruka Therapeutics, Inc.(ORKA)4,148,4284,148,4280$42.56M$46.50M3.48%+$3.94M
Spyre Therapeutics, Inc.(SYRE)2,685,4482,685,4480$43.33M$40.20M3.01%-$3.13M
Pharvaris N V
COM
3,112,7202,047,620-1,065,100$48.87M$36.04M2.70%-$12.83M
Cogent Biosciences, Inc.(COGT)5,684,4114,755,411-929,000$34.05M$34.14M2.56%+$94.2K
Jade Biosciences Inc03,220,364+3,220,364$0$32.17M2.41%+$32.17M
CytomX Therapeutics, Inc.(CTMX)013,969,882+13,969,882$0$31.71M2.38%+$31.71M
Cidara Therapeutics Inc1,051,518639,088-412,430$22.65M$31.13M2.33%+$8.48M
Upstream Bio, Inc.(UPB)2,295,3192,295,3190$14.05M$25.20M1.89%+$11.16M
Erasca, Inc.(ERAS)16,216,21617,857,083+1,640,867$22.22M$22.68M1.70%+$462.3K
Crescent Biopharma, Inc.(CBIO)01,387,864+1,387,864$0$22.40M1.68%+$22.40M
Dyne Therapeutics, Inc.(DYN)2,173,9132,173,9130$22.74M$20.70M1.55%-$2.04M
Savara Inc.(SVRA)3,257,6398,884,263+5,626,624$9.02M$20.26M1.52%+$11.23M
Dianthus Therapeutics, Inc.(DNTH)1,744,3731,000,000-744,373$31.64M$18.63M1.40%-$13.01M
Engene Holdings Inc
COM
5,046,4145,046,4140$22.61M$18.37M1.38%-$4.24M
Astria Therapeutics Inc2,457,3482,457,3480$13.12M$13.17M0.99%+$49.1K
Cullinan Therapeutics, Inc.(CGEM)1,379,9651,379,9650$10.45M$10.39M0.78%-$55.2K
ABIVAX Société AnonymeADS(ABVX)1,345,7801,345,7800$8.41M$10.30M0.77%+$1.88M
Perceptive Cap Solutions CorCL A
CL A ORD SHS
750,000750,0000$7.72M$7.96M0.60%+$240.0K
Septerna, Inc.(SEPN)0540,453+540,453$0$5.71M0.43%+$5.71M
Surrozen, Inc.(SRZN)632,931632,9310$7.38M$5.66M0.42%-$1.72M
Zura Bio LimitedCL A(ZURA)5,023,1664,631,216-391,950$6.48M$4.86M0.36%-$1.62M
Artiva Biotherapeutics, Inc.(ARTV)1,609,5691,609,5690$4.83M$2.43M0.18%-$2.40M
CASI Pharmaceuticals, Inc.(CASIF)987,259987,2590$2.13M$1.16M0.09%-$967.5K
Tenax Therapeutics, Inc.(TENX)208,33398,564-109,769$1.36M$567.7K0.04%-$796.9K
4d Molecular Therapeutics In677,6000-677,600$2.19M$0—-$2.19M
Applied Therapeutics Inc5,567,7090-5,567,709$2.72M$0—-$2.72M
Century Therapeutics, Inc.(IPSC)2,498,0690-2,498,069$1.19M$0—-$1.19M
Glycomimetics Inc3,000,0000-3,000,000$630.0K$0—-$630.0K
Instil Bio, Inc.(TIL)33,1770-33,177$576.0K$0—-$576.0K
Mersana Therapeutics Inc3,574,3250-3,574,325$1.23M$0—-$1.23M
Praxis Precision Medicines, Inc.(PRAX)989,9850-989,985$37.49M$0—-$37.49M
Solid Biosciences Inc2,481,4000-2,481,400$9.18M$0—-$9.18M
Tenaya Therapeutics, Inc.(TNYA)1,555,5560-1,555,556$886.8K$0—-$886.8K
Trevi Therapeutics, Inc.(TRVI)615,5060-615,506$3.87M$0—-$3.87M
Page 1 of 1
VR Adviser, LLC — 13F Holdings — Q2 2025 | TickerTrail